BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30517305)

  • 1. Relationships of interleukin-10 with the regulatory T cell ratio and prognosis of cervical cancer patients.
    Wang B; Wang H; Li P; Wang L; Liu H; Liu J; Wang L
    Clinics (Sao Paulo); 2018 Dec; 73():e679. PubMed ID: 30517305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
    Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
    BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of CD4+CD25+ regulatory T cells, IL-10 and TGF-beta1 levels in peripheral blood in children with asthma].
    Li M; Song L; Zhang JB; Fang J; Li L
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):829-32. PubMed ID: 19849943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Th17 and CD4
    Xiang M; Guo L; Ma Y; Li Y
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2405-2410. PubMed ID: 28167485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD4+CD25+CD127
    Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
    Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma.
    Alhamarneh O; Agada F; Madden L; Stafford N; Greenman J
    Head Neck; 2011 Mar; 33(3):415-23. PubMed ID: 20645289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating inflammatory markers in cervical cancer patients and healthy controls.
    Vitkauskaite A; Urboniene D; Celiesiute J; Jariene K; Skrodeniene E; Nadisauskiene RJ; Vaitkiene D
    J Immunotoxicol; 2020 Dec; 17(1):105-109. PubMed ID: 32364810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immune cell markers and tumor markers in patients with cervical cancer.
    Zhang L; Zhang H; Huang Y; Xi X; Sun Y
    Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
    Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
    BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of ulinastatin on immune function of spleen in severely burned rats and its mechanism].
    Li J; Hu C; Yao Y; Yang H
    Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):266-71. PubMed ID: 27188484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of interleukin-37 correlate with poor prognosis in gastric cancer.
    Zhang Y; Tang M; Wang XG; Gu JH; Zhou LN; Jin J; Li P; Wang LQ; Chen MB
    Rev Esp Enferm Dig; 2019 Dec; 111(12):941-945. PubMed ID: 31718212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
    Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
    Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection].
    Rao HP; Feng L; Li D; Bader A; Wu NP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):42-5. PubMed ID: 17484210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-6 and -10 levels in patients with gastric cancer.
    Ikeguchi M; Hatada T; Yamamoto M; Miyake T; Matsunaga T; Fukumoto Y; Yamada Y; Fukuda K; Saito H; Tatebe S
    Gastric Cancer; 2009; 12(2):95-100. PubMed ID: 19562463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significantly increased interleukin-1A and interleukin-1 soluble type II receptor levels in women with ovarian cancer].
    Kondera-Anasz Z; Mielczarek-Palacz A; Switała J
    Ginekol Pol; 2003 Sep; 74(9):761-6. PubMed ID: 14674121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
    Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
    Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.